Background
World Health Organization classification and Masaoka‐Koga stage are widely used for thymic epithelial tumors (TETs). Reduced field‐of‐view (rFOV) diffusion‐weighed imaging (DWI) proved to improve the image quality. Dynamic contrast‐enhanced (DCE) MRI was commonly used in evaluating tumors.
Purpose
To investigate the value of multiparametric MRI in evaluating TETs.
Study Type
Retrospective.
Subjects
Eighty‐seven participants including 38 low risk (52.08 ± 14.19 years), 30 high risk (52.40 ± 11.35 years), and 19 thymic carcinoma patients (59.76 ± 10.78 years).
Field strength/Sequence
A 3 T, turbo spin echo imaging, echo planar imaging, volumetric interpolated breath‐hold examination with radial acquisition trajectory.
Assessment
DCE‐MRI and apparent diffusion coefficient (ADC) variables were compared. Diagnostic performances of single significant factor and combined model were compared.
Statistical Tests
Parameters were compared using one‐way ANOVA or independent‐samples t test. Logistic regression was employed to investigate the combined model. Receiver operating curves (ROC) and DeLong's test were used to compare the diagnostic efficiency.
Results
ADC, Ktrans, and kep values were significantly different among low‐risk, high‐risk and carcinoma group (ADC, 1.279 ± 0.345 × 10−3 mm2/sec, 0.978 ± 0.260 × 10−3 mm2/sec, 0.661 ± 0.134 × 10−3 mm2/sec; Ktrans 0.167 ± 0.071 min−1, 0.254 ± 0.136 min−1, 0.393 ± 0.110 min−1; kep 0.345 ± 0.113 min−1, 0.560 ± 0.269 min−1, 0.872 ± 0.149 min−1). They were significantly different for early stage and advanced stage (ADC, 1.270 ± 0.356 × 10−3 mm2/sec vs. 0.845 ± 0.251 × 10−3 mm2/sec; Ktrans 0.179 ± 0.092 min−1 vs. 0.304 ± 0.142 min−1; kep 0.370 ± 0.181 min−1 vs. 0.674 ± 0.362 min−1). The combination of them had highest diagnostic efficiency for WHO classification (AUC, 0.925; sensitivity, 83.7%; specificity, 89.5%), clinical stage (AUC, 0.879; sensitivity, 80.9%; specificity, 82.5%).
Data Conclusion
Multiparametric MRI model may be useful for discriminating WHO classification and clinical stage of TETs.
Evidence Level
4
Technical Efficiency
Stage 2